Patents Assigned to THE TRUSIEES OF THE UNIVERSITY OF PENNSYLVANIA
  • Effects of LGM2605 on a primate model of asthma
    Patent number: 11197876
    Abstract: The invention provides compositions and methods for treating asthma in a subject in need thereof comprising administering chemically synthesized secoisolaricirecinol diglucoside (SDG), and in particular, a racemic mixture of the SDG (LGM2605), stereoisomers thereof, metabolites thereof, and analogs thereof. Also provided are methods for treating or preventing ozone-induced damage in a subject in need thereof.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: December 14, 2021
    Assignees: THE TRUSIEES OF THE UNIVERSITY OF PENNSYLVANIA, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Melpo Christofidou-Solomidou, Angela Haczku